LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis
International Journal of Sports Medicine · 01.10.2024 · 45 (11) · 856-866
DOI: 10.1055/a-2323-9749 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Sports Medicine, erschienen am 01.10.2024. Verfasst von Zhixin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Histology & Embryology Teaching and Researching Section, Xi'an Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Osteogenesis, RNA, Long Noncoding, Cell Differentiation, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for human bone formation. Long non-coding RNAs (lncRNAs) are critical regulators in osteogenic differentiation. This study aimed to explore the function and mechanisms of long intergenic non-protein coding RNA 963 (LINC00963) in affecting osteogenesis. Cell differentiation was assessed by alkaline phosphatase (ALP) activity detection and ALP staining assay. Meanwhile, levels of osteogenic marker genes, including RUNX family transcription factor 2 (RUNX2), osteocalcin (OCN), and osteopontin (OPN), were detected by RT-qPCR and western blot. Cell proliferation and apoptosis were measured using CCK-8 assay and flow cytometry analysis. RNA immunoprecipitation (RIP), RNA pull-down and luciferase reporter assays were used to investigate the interaction between genes. LINC00963 expression was down-regulated in hBMSCs treated with osteogenic induction. LINC00963 overexpression inhibited hBMSCs differentiation, proliferation, and elevated apoptosis. LINC00963 acted as a competing endogenous RNA (ceRNA) to interact with miR-10b-5p and thereby regulated the expression level of Ras-related protein Rap-2a (RAP2A). LINC00963 regulated RAP2A to inhibit the level of phosphorylated AKT (p-AKT). LINC00963 inhibited hBMSCs differentiation, proliferation, and elevated apoptosis via the miR-10b-5p/RAP2A/AKT signaling, which might help improve the treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Histology & Embryology Teaching and Researching Section, Xi'an Medical University, Xi'an, China.
- Public Health College, Xi'an Medical University, Xi'an, China.
- Department Endocrinology, Shaanxi Province People Hospital, Xi'an, China.
- Clinical College, Xi'an Medical University, Xi'an, China.
ORCID-Profile: Zhixin Wu
Zitieren
APA
Wu, Z., Shi, M., Zhao, X., Wu, G., Zheng, H., Cui, Y., & Shang, Y. (2024). LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis. International Journal of Sports Medicine, 45(11), 856-866. https://doi.org/10.1055/a-2323-9749
Vancouver
Wu Z, Shi M, Zhao X, Wu G, Zheng H, Cui Y, et al. LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis. International Journal of Sports Medicine. 2024;45(11):856-866. doi:10.1055/a-2323-9749
BibTeX
@article{Wu2024,
author = {Wu, Zhixin and Shi, Mingjuan and Zhao, Xuan and Wu, Guifu and Zheng, Huiyuan and Cui, Yuanyuan and Shang, Yu},
title = {LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis},
journal = {International Journal of Sports Medicine},
year = {2024},
volume = {45},
number = {11},
pages = {856--866},
doi = {10.1055/a-2323-9749}
}
EUVIMED